See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Wong Wan Ling, Su Xinyi, Li Xiang, Cheung Chui Ming G, Klein Ronald, Cheng Ching-Yu, Wong Tien Yin. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. The Lancet Global Health. Vol. 2(2)2014. Elsevier BV. [Cross Ref]
Tomany Sandra C., Wang Jie Jin, van Leeuwen Redmer, Klein Ronald, Mitchell Paul, Vingerling Johannes R., Klein Barbara E.K., Smith Wayne, de Jong Paulus T.V.M.. Risk factors for incident age-related macular degeneration. Ophthalmology. Vol. 111(7):1280–1287. 2004. Elsevier BV. [Cross Ref]
The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the age-related eye disease study report number 6. American Journal of Ophthalmology. Vol. 132(5):668–681. 2001. Elsevier BV. [Cross Ref]
Five-Year Follow-up of Fellow Eyes of Patients With Age-Related Macular Degeneration and Unilateral Extrafoveal Choroidal Neovascularization. Archives of Ophthalmology. Vol. 111(9)1993. American Medical Association (AMA). [Cross Ref]
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2. American Journal of Ophthalmology. Vol. 131(5):541–560. 2001. Elsevier BV. [Cross Ref]
D’Amico Donald J.. Pegaptanib Sodium for Neovascular Age-Related Macular Degeneration. Ophthalmology. Vol. 113(6)2006. Elsevier BV. [Cross Ref]